Poland Pharmaceuticals Report - 2014

October 31, 2014

This report covers the market developments in FY 2013 and the data available as of October 2014.

The Polish pharmaceutical market resumed growth in 2013, partly on low-base comparison, yet visibly, albeit slowly, recovering after the decline in 2012, when the entire pharma sector was affected by the price cut for reimbursed drugs, as part of the Reimbursed Act enforced and amended during the year.

The market rebound was visible in the first nine months of 2014 as well, yet for the full year results the flu season might make a difference for pharmacies considering the high base comparison in 2013. The pharmacies continue to be negatively affected by the fixed retail margins on reimbursable drugs, the frequent changes to the reimbursable drug list and the pharmacy advertising ban.

The OTC sales continued to record dynamic annual growth in 2013, partly on low base comparison, but also fuelled by high demand in the context of long winter and high incidence of seasonal infections. In January-August 2014 the OTC sales inched down marginally y/y and the full year growth pace is expected to be lower than in 2013, yet the incidence of diseases during the cold season might drive sales upwards towards the yearend.

The pharmaceutical market is expected to continue on upward path this year, but at a slower pace compared to 2013. At pharmacy retail level, the market is expected to grow by approximately 2-4% y/y, while at distributors’ level the market is forecasted to grow by around 3-6% y/y in 2014, according to players’ estimates.

Key points:
• Pharmaceutical sales value returns to y/y growth in 2013
• Market rebound is further visible in Jan-Sep 2014
• Parallel exports surge, driven by low drug prices
• Profitability, revenues of top distributors improve y/y in 2013
• Polpharma plans investments in two production facilities
• Neuca to broaden activity range, plans developing medical clinic chain
• Pelion takes over cosmetics chain Drogerie Natura
• Neuca acquires two clinic operators in July 2014, health centre later in October

To view this extensive report in full including details such as —

  • Macroeconomic Analysis
  • Politics Analysis
  • Industrial sectors and trade
  • FX, Financials and Capital Markets
  • And more!

For a one-off purchase click here

For an annual subscription click here

For a free sample click here

Related Reports

Russia country report - March, 2024

Russia's economic growth accelerated in January 2024, expanding by 4.6% y/y, up from a 4.4% increase in December, according to the Russian Ministry of Economic Development. Both industrial ... more

Ukraine country report - February, 2024

Ukraine's economy grew 5% in 2023, far better than anyone expected, following a substantial decline of 28.8% in 2022, according to Yulia Svyrydenko, the First Deputy Prime Minister and Minister of ... more

Russia country report - February, 2024

The latest revisions to Rosstat data says that Russia ended 2023 with even better growth than the 3.5% expected at 4%. This is almost double the 2.2% expected as late as December. The military ... more

Dismiss